Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy

Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy • • • By Jonathan J. Bei tier, M.D., M.B.A., Richard V. Smith, M.D., Carl E. Silver, M.D., Robin Mitnick, M.D., Igbal Habib, B.Sc, Jacqueline A. Bello, M.D., and Lawrence W. Davis, M.D. Introduction physical exam and either a CT or an MRI scan. Often patients with unilateral complaints have early radiographie evidence of cystic lesions of the contralateral parotid, which is therefore included as 1.5 Gy daily fractions to palliate their cosmetic complaints. Patients were simulated using metal tape to outline the lesions, and to aid in the drawing of customized blocks (Figures la and b). All patients with bilateral disease were treated with parallel, opposed 6 MV photons, prescribed to encompass the target volume. Fifteen patients underwent therapy. Their characteristics and dosages are shown in Table 1. Our therapeutic goal was to achieve and maintain cosmetic control to the patient's satisfaction. In this study, the duration of cosmetic control was from completion of the radiation therapy until the patient claimed a cosmetic deformity. In a patient with bilateral disease, loss of cosmetic control on either side would be a cosmetic failure. Results from the previous study2 were http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AIDS Patient Care Mary Ann Liebert

Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy

Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy

AIDS Patient Care , Volume 9 (6) – Dec 1, 1995

Abstract

Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy • • • By Jonathan J. Bei tier, M.D., M.B.A., Richard V. Smith, M.D., Carl E. Silver, M.D., Robin Mitnick, M.D., Igbal Habib, B.Sc, Jacqueline A. Bello, M.D., and Lawrence W. Davis, M.D. Introduction physical exam and either a CT or an MRI scan. Often patients with unilateral complaints have early radiographie evidence of cystic lesions of the contralateral parotid, which is therefore included as 1.5 Gy daily fractions to palliate their cosmetic complaints. Patients were simulated using metal tape to outline the lesions, and to aid in the drawing of customized blocks (Figures la and b). All patients with bilateral disease were treated with parallel, opposed 6 MV photons, prescribed to encompass the target volume. Fifteen patients underwent therapy. Their characteristics and dosages are shown in Table 1. Our therapeutic goal was to achieve and maintain cosmetic control to the patient's satisfaction. In this study, the duration of cosmetic control was from completion of the radiation therapy until the patient claimed a cosmetic deformity. In a patient with bilateral disease, loss of cosmetic control on either side would be a cosmetic failure. Results from the previous study2 were

Loading next page...
 
/lp/mary-ann-liebert/cosmetic-control-of-parotid-gland-hypertrophy-using-radiation-therapy-9qnjlx0lY7
Publisher
Mary Ann Liebert
Copyright
Copyright 1995 Mary Ann Liebert, Inc.
ISSN
0893-5068
eISSN
1557-7449
DOI
10.1089/apc.1995.9.271
Publisher site
See Article on Publisher Site

Abstract

Cosmetic Control of Parotid Gland Hypertrophy Using Radiation Therapy • • • By Jonathan J. Bei tier, M.D., M.B.A., Richard V. Smith, M.D., Carl E. Silver, M.D., Robin Mitnick, M.D., Igbal Habib, B.Sc, Jacqueline A. Bello, M.D., and Lawrence W. Davis, M.D. Introduction physical exam and either a CT or an MRI scan. Often patients with unilateral complaints have early radiographie evidence of cystic lesions of the contralateral parotid, which is therefore included as 1.5 Gy daily fractions to palliate their cosmetic complaints. Patients were simulated using metal tape to outline the lesions, and to aid in the drawing of customized blocks (Figures la and b). All patients with bilateral disease were treated with parallel, opposed 6 MV photons, prescribed to encompass the target volume. Fifteen patients underwent therapy. Their characteristics and dosages are shown in Table 1. Our therapeutic goal was to achieve and maintain cosmetic control to the patient's satisfaction. In this study, the duration of cosmetic control was from completion of the radiation therapy until the patient claimed a cosmetic deformity. In a patient with bilateral disease, loss of cosmetic control on either side would be a cosmetic failure. Results from the previous study2 were

Journal

AIDS Patient CareMary Ann Liebert

Published: Dec 1, 1995

There are no references for this article.